Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(2.31)
# 2,959
Out of 4,408 analysts
418
Total ratings
35.6%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Initiated Coverage: Buy | $90 | $80.79 | +11.40% | 1 | Jun 15, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $32 | $32.22 | -0.68% | 28 | Jun 10, 2026 | |
| VCYT Veracyte | Reiterated: Hold | $42 | $49.15 | -14.55% | 10 | Jun 2, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 | $52.32 | +52.91% | 9 | Jun 2, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $80 | $59.81 | +33.76% | 14 | Jun 1, 2026 | |
| GH Guardant Health | Reiterated: Buy | $135 | $129.82 | +3.99% | 38 | May 28, 2026 | |
| QTRX Quanterix | Maintained: Hold | $4 | $3.10 | +29.03% | 30 | May 27, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $1.00 | +200.00% | 19 | May 15, 2026 | |
| SEER Seer, Inc. | Reiterated: Buy | $4 | $1.71 | +133.92% | 2 | May 14, 2026 | |
| XGN Exagen | Maintained: Buy | $8 | $4.57 | +75.05% | 25 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.32 | +127.27% | 33 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $285 | $216.97 | +31.35% | 34 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.9885 | +1.16% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $18.18 | +21.01% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 | $130.87 | +10.80% | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $20.66 | +93.61% | 26 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $22 | $15.60 | +41.03% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $75 | $61.32 | +22.31% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $140 | $166.89 | -16.11% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 250p → 200p | $118.20 | +69.20% | 8 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $0.0004 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $15 | $14.33 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.83 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.44 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.4927 | n/a | 1 | Jan 28, 2021 |
Twist Bioscience
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $90
Current: $80.79
Upside: +11.40%
10x Genomics
Jun 10, 2026
Reiterated: Buy
Price Target: $32
Current: $32.22
Upside: -0.68%
Veracyte
Jun 2, 2026
Reiterated: Hold
Price Target: $42
Current: $49.15
Upside: -14.55%
Tempus AI
Jun 2, 2026
Reiterated: Buy
Price Target: $80
Current: $52.32
Upside: +52.91%
GRAIL
Jun 1, 2026
Reiterated: Buy
Price Target: $80
Current: $59.81
Upside: +33.76%
Guardant Health
May 28, 2026
Reiterated: Buy
Price Target: $135
Current: $129.82
Upside: +3.99%
Quanterix
May 27, 2026
Maintained: Hold
Price Target: $4
Current: $3.10
Upside: +29.03%
Lucid Diagnostics
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $1.00
Upside: +200.00%
Seer, Inc.
May 14, 2026
Reiterated: Buy
Price Target: $4
Current: $1.71
Upside: +133.92%
Exagen
May 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.57
Upside: +75.05%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $1.32
Upside: +127.27%
May 8, 2026
Reiterated: Buy
Price Target: $285
Current: $216.97
Upside: +31.35%
May 8, 2026
Maintained: Hold
Price Target: $1
Current: $0.9885
Upside: +1.16%
May 8, 2026
Reiterated: Hold
Price Target: $22
Current: $18.18
Upside: +21.01%
May 6, 2026
Maintained: Hold
Price Target: $145
Current: $130.87
Upside: +10.80%
May 6, 2026
Maintained: Buy
Price Target: $40
Current: $20.66
Upside: +93.61%
May 5, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $15.60
Upside: +41.03%
May 5, 2026
Reiterated: Buy
Price Target: $100 → $75
Current: $61.32
Upside: +22.31%
May 1, 2026
Reiterated: Hold
Price Target: $150 → $140
Current: $166.89
Upside: -16.11%
Apr 20, 2026
Maintained: Buy
Price Target: 250p → 200p
Current: $118.20
Upside: +69.20%
Jul 29, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $0.0004
Upside: n/a
Jun 1, 2021
Maintained: Buy
Price Target: $13 → $15
Current: $14.33
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $4.83
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $1.44
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.4927
Upside: n/a